Michelle Prisner
Family · Burlington, IANPI 1538595640
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Lilly USA, LLC at 58.8% of the total. That places this record below the midpoint for family clinicians in IA, where the typical reported total is $223.
Across 6 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$66
- AbbVie$25
- Biodelivery Sciences International, Inc.$21
What the payments were for
- Food & beverage$112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 4 | $66 |
| AbbVie | 1 | $25 |
| Biodelivery Sciences International, Inc. | 1 | $21 |
How this compares
$112 in reported general payments places this provider in the 35th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $22,942 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $11,048 |
| TradjentaLinagliptin | 13 | $6,494 |
| JanuviaSitagliptin Phosphate | 17 | $4,833 |
| JardianceEmpagliflozin | 12 | $3,500 |
| Gabapentin | 65 | $2,294 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 15 | $2,059 |
| Fentanyl | 20 | $1,987 |
| Quetiapine Fumarate | 33 | $1,876 |
| Levothyroxine Sodium | 95 | $1,414 |
| Buspirone Hcl | 49 | $1,397 |
| Ropinirole Hcl | 28 | $1,341 |
| Duloxetine Hcl | 45 | $1,215 |
| Fluvoxamine Maleate | 19 | $1,146 |
| Diclofenac Sodium | 42 | $1,141 |
Paid to pharmacies, not to this prescriber.
Other family in Burlington
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.